Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 8795.T
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio 12.26 20.52 18.28
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -90.66 39.25 -420.36
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 21.47 2641.48 2174.58
Cash 0.62 4628.10 4599.60
Capex 0.00 0.00 0.00
Free Cash Flow inf 0.00 19.41
Revenue -10.37 1330.92 1484.96
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin 0.00 1.00 1.00
Operating Margin 803660.88 0.14 < 0.005
ROA 53.66 < 0.005 < 0.005
ROE 30.47 0.02 0.02
ROIC 638600.95 0.05 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 8795.T is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 8795.T is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 8795.T is permitted for members.